Elena Ridloff
Direktor/Vorstandsmitglied bei KRONOS BIO, INC.
Vermögen: 13 684 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Nello Mainolfi | M | 45 | 9 Jahre | |
| Felix Baker | M | 55 | 7 Jahre | |
| Ellen Chiniara | F | 65 | 5 Jahre | |
| Michael Cloonan | M | 53 |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | - |
| Adam Rosenberg | M | 54 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | - |
| Bruce Booth | M | 49 | 8 Jahre | |
| Bruce Jacobs | M | 54 | 5 Jahre | |
| Allison Frisbee | F | 41 | 4 Jahre | |
| David Tanen | M | 52 | 7 Jahre | |
| Tai Yin Yang | M | 70 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | 3 Jahre |
| Arie Belldegrun | M | 74 | 7 Jahre | |
| Joshua Kazam | M | 47 | 7 Jahre | |
| Leigh Morgan | F | - | 2 Jahre | |
| Piyush Sharma | M | - | 7 Jahre | |
| Brian Albarran | M | - | 6 Jahre | |
| Brendan Teehan | M | 56 | 6 Jahre | |
| Katherine Stultz | F | 51 | 1 Jahre | |
| Elizabeth Garofalo | M | 66 | 4 Jahre | |
| Mark Schneyer | M | 50 | 4 Jahre | |
| Gorjan Hrustanovic | M | 35 | 4 Jahre | |
| Roger Dansey | M | 68 | 1 Jahre | |
| Roshawn Blunt | F | 49 | 3 Jahre | |
| Norbert W. Bischofberger | M | 68 | 6 Jahre | |
| Elizabeth A. Olek | M | 59 | 2 Jahre | |
| Jeffrey Albers | M | 52 | 4 Jahre | |
| Katherine Bishop | M | 58 | 3 Jahre | |
| Joanna Horobin | M | 69 | 6 Jahre | |
| John Maraganore | M | 60 | 2 Jahre | |
| Howard Marks | M | 77 |
University of Pennsylvania
| 24 Jahre |
| Paul Clancy | M | 62 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | 5 Jahre |
| Victor Sandor | M | 57 | 2 Jahre | |
| Matthew Kinsella | M | - |
Maverick Capital Ltd.
 Maverick Capital Ltd. Investment ManagersFinance Maverick Capital Ltd. (Maverick) is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. They are a wholly-owned subsidiary of Cohasset Ltd. The firm was founded by Lee Ainslie III in 1993. Maverick provides advisory services to hedge funds, funds of funds, funds making venture capital investments, a private equity fund and related co-investment vehicle, other pooled investment vehicles, and institutional investors. | 19 Jahre |
| Pamela Esposito | M | 50 | 4 Jahre | |
| Joshua Resnick | M | 49 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | - |
| Charles Lin | M | 39 | 5 Jahre | |
| Aimee Mishkin | F | - | 4 Jahre | |
| David Tykocinski | M | - |
Maverick Capital Ltd.
Maverick Capital Ltd. Investment ManagersFinance Maverick Capital Ltd. (Maverick) is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. They are a wholly-owned subsidiary of Cohasset Ltd. The firm was founded by Lee Ainslie III in 1993. Maverick provides advisory services to hedge funds, funds of funds, funds making venture capital investments, a private equity fund and related co-investment vehicle, other pooled investment vehicles, and institutional investors. | 13 Jahre |
| Sanjeev Pathak | M | - | 3 Jahre | |
| Melissa Brody | F | - | 3 Jahre | |
| Karen Weisbach | F | - | 3 Jahre | |
| Juliet Williams | M | - | 3 Jahre | |
| Sandra Gardiner | F | 58 | 1 Jahre | |
| Rocio Martin Hoyos | F | - | 3 Jahre | |
| Ponni Subbiah | M | - | 5 Jahre | |
| Ashwin Gollerkeri | M | - | 3 Jahre | |
| Kevin Dushney | M | - | 3 Jahre | |
| Raphael Amit | M | 77 |
University of Pennsylvania
| 25 Jahre |
| Justine E. Koenigsberg | F | - | 1 Jahre | |
| James Kihara | M | - | 4 Jahre | |
| Vijay Sabesan | M | 51 | 3 Jahre | |
| Jeremy Chadwick | M | 61 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Leonard Bell | M | 65 | 25 Jahre | |
| Aradhana Sarin | M | 50 | - | |
| Joseph A. Madri | M | 80 | 22 Jahre | |
| David Brennan | M | 70 | 7 Jahre | |
| David Hallal | M | 57 | 10 Jahre | |
| Barbara Kosacz | F | 66 | 4 Jahre | |
| Kory Wentworth | M | 45 | 9 Jahre | |
| Stephen P. Squinto | M | 67 | 23 Jahre | |
| Sassan Alizadeh | M | - |
University of Pennsylvania
| 7 Jahre |
| Stephanie Fagan | F | - | 2 Jahre | |
| Nehal Kamalapat Chopra | F | - |
University of Pennsylvania
| 4 Jahre |
| Jonathan Keehn | M | - |
Maverick Capital Ltd.
Maverick Capital Ltd. Investment ManagersFinance Maverick Capital Ltd. (Maverick) is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. They are a wholly-owned subsidiary of Cohasset Ltd. The firm was founded by Lee Ainslie III in 1993. Maverick provides advisory services to hedge funds, funds of funds, funds making venture capital investments, a private equity fund and related co-investment vehicle, other pooled investment vehicles, and institutional investors. | - |
| Andrew Hedin | M | 39 | 3 Jahre | |
| Rebecka Belldegrun | M | - | - | |
| Bill Belleville | M | - |
University of Pennsylvania
| 2 Jahre |
| Jakob Loven | M | 46 | - | |
| Todd Young | M | 52 | 2 Jahre | |
| John C. King | M | 49 | 9 Jahre | |
| Yasir Al-Wakeel | M | 42 | 3 Jahre | |
| Susan Altschuller | M | 42 | 2 Jahre | |
| Sean Evan Wright | M | 50 |
University of Pennsylvania
| 2 Jahre |
| Mark Day | M | 52 | 2 Jahre | |
| Rana Strellis | F | - | 4 Jahre | |
| Robert Doebele | M | 53 |
University of Pennsylvania
| 4 Jahre |
| Maja Sliwinski | F | - |
University of Pennsylvania
| 6 Jahre |
| Brian Goff | M | 55 | 4 Jahre | |
| Christopher Coughlin | M | 71 | 7 Jahre | |
| Ludwig Hantson | M | 61 | 4 Jahre | |
| Paul Friedman | M | 81 | 4 Jahre | |
| Salvatore Tirabassi | M | - |
University of Pennsylvania
| 3 Jahre |
| Francois Nader | M | 67 | 4 Jahre | |
| Anne-Marie Law | F | 56 | 3 Jahre | |
| Rockford Norby | M | 88 | 18 Jahre | |
| John Martin | M | 72 | - | |
| M. Burns | F | 66 | 4 Jahre | |
| Michael Weiser | M | 61 |
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | 7 Jahre |
| Mehul Trivedi | M | 53 |
University of Pennsylvania
| 9 Jahre |
| James S. Riepe | M | - |
University of Pennsylvania
| 4 Jahre |
| Glenn F. Baity | M | 54 | 14 Jahre | |
| Erika G. Long | F | - |
Maverick Capital Ltd.
Maverick Capital Ltd. Investment ManagersFinance Maverick Capital Ltd. (Maverick) is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. They are a wholly-owned subsidiary of Cohasset Ltd. The firm was founded by Lee Ainslie III in 1993. Maverick provides advisory services to hedge funds, funds of funds, funds making venture capital investments, a private equity fund and related co-investment vehicle, other pooled investment vehicles, and institutional investors. | - |
| Saam Farhang | M | - |
University of Pennsylvania
| 5 Jahre |
| Taran Sang Yong Bae | M | - |
University of Pennsylvania
| 2 Jahre |
| Otello Stampacchia | M | 55 | 5 Jahre | |
| Steve Hall | M | 69 | 5 Jahre | |
| William Keller | M | 75 | 6 Jahre | |
| Jack Mollen | M | 73 | 7 Jahre | |
| Larry L. Mathis | M | 80 | 10 Jahre | |
| Austin Kim | M | 60 | 6 Jahre | |
| Karen Martin | M | - | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Elena Ridloff
- Persönliches Netzwerk
